North America Custom Antibody Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Custom Antibody Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Custom Antibody Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Custom Antibody Services Market Regional Analysis

6.2 North America Custom Antibody Services Market Revenue 2021-2031 (US$ Million)

6.3 North America Custom Antibody Services Market Forecast Analysis

7. North America Custom Antibody Services Market Analysis – by Product Type

7.1 Monoclonal

7.1.1 Overview
7.1.2 Monoclonal: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Polyclonal Hybridoma

7.2.1 Overview
7.2.2 Polyclonal Hybridoma: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Recombinant Antibody

7.3.1 Overview
7.3.2 Recombinant Antibody: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Others

7.4.1 Overview
7.4.2 Others: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Custom Antibody Services Market Analysis – by Service Type

8.1 Antibody Discovery and Development

8.1.1 Overview
8.1.2 Antibody Discovery and Development: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Antibody Production Services

8.2.1 Overview
8.2.2 Antibody Production Services: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Others

8.3.1 Overview
8.3.2 Others: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Custom Antibody Services Market Analysis – by Disease Indication

9.1 Oncology

9.1.1 Overview
9.1.2 Oncology: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Infectious Diseases: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Immunology

9.3.1 Overview
9.3.2 Immunology: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.4 Cardiovascular Diseases

9.4.1 Overview
9.4.2 Cardiovascular Diseases: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.5 Others

9.5.1 Overview
9.5.2 Others: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Custom Antibody Services Market Analysis – by Source

10.1 Chicken

10.1.1 Overview
10.1.2 Chicken: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Rabbits

10.2.1 Overview
10.2.2 Rabbits: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Rats

10.3.1 Overview
10.3.2 Rats: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Guinea Pigs

10.4.1 Overview
10.4.2 Guinea Pigs: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.5 Mouse or Humanized Mice

10.5.1 Overview
10.5.2 Mouse or Humanized Mice: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.6 Others

10.6.1 Overview
10.6.2 Others: North America Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Custom Antibody Services Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Custom Antibody Services Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 North America Custom Antibody Services Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 US: North America Custom Antibody Services Market Breakdown, by Product Type
11.2.1.1.2 US: North America Custom Antibody Services Market Breakdown, by Service Type
11.2.1.1.3 US: North America Custom Antibody Services Market Breakdown, by Disease Indication
11.2.1.1.4 US: North America Custom Antibody Services Market Breakdown, by Source

11.2.1.2 Canada: North America Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Canada: North America Custom Antibody Services Market Breakdown, by Product Type
11.2.1.2.2 Canada: North America Custom Antibody Services Market Breakdown, by Service Type
11.2.1.2.3 Canada: North America Custom Antibody Services Market Breakdown, by Disease Indication
11.2.1.2.4 Canada: North America Custom Antibody Services Market Breakdown, by Source

11.2.1.3 Mexico: North America Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Mexico: North America Custom Antibody Services Market Breakdown, by Product Type
11.2.1.3.2 Mexico: North America Custom Antibody Services Market Breakdown, by Service Type
11.2.1.3.3 Mexico: North America Custom Antibody Services Market Breakdown, by Disease Indication
11.2.1.3.4 Mexico: North America Custom Antibody Services Market Breakdown, by Source

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Thermo Fisher Scientific Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Sino Biological Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 GenScript Biotech Corporation

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Biochain Incorporated

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 R&D Systems, Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Kaneka Eurogentec S.A.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Fortis Life Sciences

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Precision Antibody (A&G Pharmaceutical, Inc.)

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Biocytogen Pharmaceuticals Beijing Co Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Abgenex

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Creative Biolabs Inc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Agilent Technologies Inc

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 Bioklone

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 Scantibodies Laboratory, Inc.

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Custom Antibody Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis